Vaccines are one of the few truly cost-effective health care interventions, but only effective if they are used. There are many reasons for vaccine hesitancy, and no one way to raise vaccination rates, but a variety of methods can make it easier to get people vaccinated.
All medical interventions involve risk, and require accepting a degree of uncertainty in the outcome because the evidence is imperfect.
The vaccine risk
The data we have about a drug when it is first approved is the least information we will ever have about it — More is to be learned in post market study or from real world evidence generation. Clinical trials don’t include all types of people who will take the treatment. Often certain races and ethnicities are underrepresented. No individual person’s response or side effects are accurately described in a clinical trial of hundreds or thousands of people.
So, we rely on health care providers, scientific institutions and often trusted people in our community or friend group when deciding to get a vaccine or other preventive care treatment. We know that misinformation and lack of trust in healthcare and science is not helpful, but we also know what has worked in the past.
There have been many useful analyses of the factors that contributed to a high percentage of the population getting vaccinated for COVID-19. These lessons from this great national tragedy of the pandemic followed by the triumph of a technology that dramatically reduced the death rates from COVID-19 are a success that can be built on.
Access and clarity
One of the critical factors that led to successfully vaccinating people during the pandemic was eliminating cost sharing and providing convenient places to get the vaccination. It is well established that making preventive care convenient is a way to increase treatment and diagnoses of underlying disease. This includes having care available in pharmacies, workplaces, and community events.
Another avenue to improve vaccination rates are clear guidelines for the public. Clear guidelines help deputize the patient to know when it is time to seek out preventive care. During the pandemic people knew at what age and with what risk factors they were eligible for a shot.
Most middle-aged people know the magic age when it is time to get a mammogram or a colonoscopy because the guidelines are clear and well communicated. Our health providers have a high burden placed on them already. Adding extra layers of complication to a vaccine recommendation is passing responsibility from the delegated authority to the individual provider.
But clear communication and guidelines do not mean that there is a one-size fits all. The age for a vaccine or other preventive service may vary depending on certain risks. That was clearly communicated in the COVID-19 pandemic and people were able to understand and show up when it was their turn. For some higher risk groups the vaccine may have benefits at an earlier age.
As we gain a wealth of data about differences in health outcomes and risks of disease in different populations, as we did in the pandemic, we should use that information to create guidelines that meet all patients’ needs.
Countering distrust
The growing distrust in medicines is not a new phenomenon. Yet its prevalence and rise following the highly politicized COVID-19 vaccine debate presents a new challenge for public health.
As we continue to live in the cloud of misinformation, we have to use the other tools we have: convenient access to care, clear and targeted guidelines, clear communication about risk and benefit and trusted intermediaries to encourage the use of lifesaving vaccines for individual and public health.
Kirsten Axelsen is a nonresident fellow at the American Enterprise Institute and a consultant to biopharmaceutical and other life science companies.





Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.